The global new drug delivery systems (NDDS) market is anticipated to grow at a CAGR of 21.6% during the forecast period (2024-2031). Nanomedicine plays a significant role in various areas of healthcare, including cancer treatment, diabetes management, pain management, neurological disorders, respiratory disorders, cardiovascular diseases, and infectious diseases. It offers targeted drug delivery, reduces systemic toxicity, and enhances the effectiveness of medications through the use of different drug delivery systems such as liposomal formulations, polymer-based nanoparticles, transdermal patches, inhalable formulations, and implantable devices.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/ndds-market
These advancements in nanotechnology aim to improve patient outcomes and minimize adverse effects associated with traditional treatments. The market’s growth is attributed to the increasing demand for chronic diseases. The growth in chronic diseases needs improved drug delivery systems. NDDS has the potential to improve disease management by providing controlled and sustained drug release, that aligns with the demands of patients that require long-term medication therapy. For instance, in March 2022, Gufic Biosciences has launched indigenous New Drug Delivery System (NDDS) named Dual Chamber Bags (DCB).The most essential component of these Dual Chamber Bags is their ability to prevent contamination while additionally protecting the drug’s potency and efficiency. The DCB closed system ensures that the product is appropriate and minimizes the possibility of contamination during handling.
Global New Drug Delivery Systems (NDDS) Market Report Segment
By Route of Administration
- Oral Drug Delivery Systems (DDS)
- Injectable Drug Delivery Systems (DDS)
- Pulmonary Drug Delivery Systems (DDS)
- Transdermal Drug Delivery Systems (DDS)
- Others (Nasal Drug Delivery Systems (DDS), and Implantable Drug Delivery Systems (DDS))
By Mode of NDDS
- Targeted Drug Delivery Systems
- Controlled Drug Delivery Systems
- Modulated Drug Delivery Systems
- Others (Biologics-Based Drug Delivery Systems, and Nanotechnology-Based Drug Delivery Systems)
A full report of New Drug Delivery Systems (NDDS) Market available @ https://www.omrglobal.com/industry-reports/ndds-market
New Drug Delivery Systems (NDDS) Market Report Segment by Region
North America
- United States
- Canada
Europe
- Germany
- United Kingdom
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
Rest of the World
- Middle East & Africa
- Latin America
Company Profiles
- Bayer AG
- Boston Scientific Corp.
- Bristol Myers Squibb (BMS)
- Celgene Corp.
- At F. Hoffmann-La Roche Ltd.
- GlaxoSmithKline PLC
- Johnson & Johnson Services, Inc.
- Merck KGaA,
- Novartis International AG
- Pfizer Inc.
- Assertio Holdings, Inc.
Reasons to Buying From us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
